Mohammad AskarPublic working copy · medical review pending

Consultations · 035

Ophthalmic consultations: assess, explain and agree the plan

Begin with urgency, then connect symptoms, tests and patient goals. Source conversation fragments illustrate communication; they are not verified treatment protocols.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Separate a measured finding from its interpretation and a proposed treatment from an agreed decision. Give a specific follow-up and warning plan.

Terminology and draft status

Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.

01Establish urgency before routine consultation

The export describes consultation patterns, not a verified clinical trial or case record. Retain blurred vision, flashes, watering, itching, burning, foreign-body sensation and headache as starting complaints; ask about onset, laterality, duration and associated symptoms. 1

New flashes or floaters, field shadow, curtain or sudden visual loss need urgent assessment; bilateral flashes alone do not establish migraine. A transient grey curtain may represent retinal ischaemia but is not proved carotid disease from the description alone. 8 9

For suspected transient ischaemic attack (TIA), NICE recommends immediate referral for specialist assessment within 24 hours. Acute ongoing neurological symptoms require emergency care; do not defer them to a routine ophthalmic review or prescribe a universal vascular regimen from this lecture. 9

Ask about diabetes, blood pressure, cardiovascular disease, medicines, eye drops, allergies and prior surgery or laser. Link the complaint to examination findings rather than assuming that an existing diagnosis explains every new symptom. 1 6 7

02Measure and interpret findings in context

Measure acuity with method, correction and laterality recorded. The exported chart fragments 759486, 2893464527 and “08 b bis 10 b” are unverified transcription examples, not valid acuity results or patient identifiers established by this review. 1

Subjective refraction compares lenses and asks which is clearer. Discuss distance, reading or progressive spectacles according to tasks and adaptation; clearer letters with a lens do not exclude retinal or optic-nerve disease. 1 12

Pupil dilation improves examination of retina and optic nerve. The original 4–5-hour driving warning is a source example, not a universal clearance time; follow the actual drops and local advice, and do not drive while vision remains affected. 11 1

The export calls pressures of 13 in the right and 15 in the left eye “good”; the units and method need confirmation in the original record. A pressure value alone neither diagnoses nor excludes glaucoma: examine the disc, fields and angle and assess change over time. 6 1

Slit-lamp examination assesses ocular tissues; optical coherence tomography (OCT) depicts retinal layers and the macula, including oedema, and perimetry tests visual fields. Stereo rings, colour plates and Mesotest assess distinct functions; a “normal” result in one does not certify all visual function or driving fitness. 6 7 1

03Explain cataract and posterior capsule opacity accurately

Cataract is lens opacity that can impair clarity, contrast, glare tolerance and colour perception. A clearer colour impression after surgery is plausible, but the ambiguous exported “Schumann” wording is not a verified diagnosis. 2 1

Surgery removes the cataractous lens material and replaces its optical function with an intraocular lens. Referral depends on functional impact, preferences, comorbidity and benefit–risk discussion, rather than implying that every cataract must be operated immediately or using acuity alone. 2

The original “front shell and nucleus removed, back shell retained” is a simplified explanation: an opening is made in the anterior capsule and lens material removed; remaining capsule usually supports the implant. Explain that individual techniques or complications can alter this arrangement. 2 3 1

Posterior capsule opacification is clouding behind the implant, not cataract regrowth. Nd:YAG capsulotomy can improve vision when the opacity is causative, but “completely harmless and easily removed” omits pressure rise, inflammation or macular swelling and retinal-detachment risk; assess indication and counsel before treatment. 3

04Treat surface symptoms and glaucoma with individual plans

Dry eye can cause burning, foreign-body sensation and fluctuating vision; watering may reflect reflex tearing but also allergy, lacrimal disease or other pathology. Diagnose from symptoms and ocular-surface assessment rather than reassuring that everything is “only dryness” before examination. 5

Lubricants are an option within cause-directed management. The original 2–3-times-daily instruction is not a universal regimen: formulation, preservatives, severity and response matter. A Cochrane review of 43 trials/3497 participants found limited, low-quality comparative evidence; no one preparation or frequency is thereby best for everyone. 4 5 1

Glaucoma follow-up considers optic-nerve damage, fields, pressure, target pressure and progression. Recheck technique, adverse effects, cost or practical barriers when asking about adherence; avoiding drops does not prove an inevitable individual blindness outcome. 6

Replace “if you do not use drops, you will go blind” with a clear explanation of untreated disease risk and the expected benefit and burden of the agreed treatment. Confirm what the patient can do and arrange a specific review plan; do not use fear as a substitute for informed agreement. 6 12 1

05Recognize different retinal pathways

Diabetes care includes retinal assessment even without visual complaints; a normal examination now does not remove future risk. Distinguish screening from specialist monitoring and document retinopathy stage, macular involvement and systemic risk rather than simply “sugar check”. 7

Some diabetic disease needs observation; selected proliferative or macular disease may need laser, intravitreal treatment or surgery. The unclear export fragment about an old “Forama” and “Leder” is not verified evidence of a retinal procedure; preserve it as unresolved provenance and assess new flashes for new retinal tears despite any prior treatment. 7 8 1

Suspected active ocular toxoplasmosis requires assessment of lesion location, activity, vitritis, vision and immune status. Oedema means fluid and gliosis scar-related change; neither word alone identifies the active cause. Antimicrobial treatment and selected intravitreal therapy are specialist options, not interchangeable generic “injections”. 10 1

A randomized single-masked 68-patient toxoplasmosis trial compared intravitreal clindamycin/dexamethasone with systemic classic treatment. Lesion-size reduction at 6 weeks did not differ significantly; this does not prove equivalence or justify a universal injection rule. Small size, selected disease and incomplete full-report appraisal limit application. 10

06Agree the explanation, treatment and follow-up

Use short, one-step examination instructions and explain what the test contributes. Discuss options, benefits, harms and the option of no immediate change when appropriate; ask the patient to explain the agreed plan in their own words. 12

The original follow-up examples 6 weeks,6 months and 1 year are communication examples, not schedules for every condition. State the diagnosis, reason for review and what would bring the appointment forward; screening intervals and active-disease monitoring have different purposes. 1 6 7 12

Provide written safety-net instructions for sudden visual loss, new curtain or numerous flashes, floaters, pain or acute neurological symptoms. Check access to urgent care and invite questions; the original conversation analysis does not establish that any quoted phrase improves outcomes. 8 9 12

Agree the explanation, treatment and follow-up
CategoryPurposeExample
Examination instructionsOne clear action at a time.Look at the light; read the last line; look at my ear or upward as requested.
Explain findingsConnect observation and uncertainty.Lens opacity can explain blur; assess whether capsule opacity or dry eye causes the complaint.
Discuss treatmentExplain options without a guaranteed result.Consider surgery, laser or lubricant when indicated; explain what an injection would treat before a proposed last trial.
Follow-upGive reason, timing and earlier-return criteria.Examples 6 weeks,6 months or 1 year need disease-specific justification.
What are the main learning points of this lecture?

The chapters connect findings, meaning and next steps. Check diagnosis, alternatives and source limits against the individual clinical findings.

Which findings require urgent assessment?

Rapid visual deterioration, severe pain, marked inflammation, pressure rise or suspected infection/neurological disease require urgent assessment. Apply the topic-specific warning signs and clinical context.

References and access status

  1. 1
    Original consultation export

    Complete local lecture/wrapper read; recordings, transcripts, speaker attribution and ambiguous strings unchecked.

  2. 2
    NICE NG77 cataracts, recommendations

    Actual selected information/referral sections read; overview last reviewed20May2025. Not whole guideline/evidence reports.

  3. 3
    AAO posterior capsulotomy patient teaching

    Actual indexed procedure/risk text read; educational patient text, not full operative guideline.

  4. 4
    Cochrane OTC tears2016, PMID26905373

    Complete actual PubMed XML abstract read; main, protocol and included trials unread.

  5. 5
    TFOS DEWS III management2025, PMID40467022

    Complete actual PubMed XML abstract read; full report and underlying evidence not appraised.

  6. 6
    NICE NG81 glaucoma recommendations

    Actual selected case-finding/reassessment passages read; not whole guideline or current local drug-label review.

  7. 7
    NICE NG242 diabetic retinopathy2024

    Actual selected DMO discussion/treatment and scope text read; complete evidence reports unread.

  8. 8
    AAO floaters/flashes,3November2026

    Actual indexed symptom and urgent-warning text read; patient education, not a full retinal examination protocol.

  9. 9
    NICE NG128 suspected TIA

    Actual selected initial-recognition/referral text read; full guideline, local emergency protocols and drug prescribing not appraised.

  10. 10
    Soheilian toxoplasmosisRCT2011, PMID20708269

    Complete actual PubMed XML abstract read; full methods, allocation, masking, protocol and supplements unread.

  11. 11
    East Sussex NHS dilation advice

    Complete actual patient page read; programme-specific advice, not universal German driving law or product information.

  12. 12
    NICE NG197 shared decision making

    Actual indexed recommendation/PDF excerpts on options, harms and teach-back read; direct chapter403. Full evidence unread.